can't sleep on tirzepatide Will Keep Me Awake at Night or Disrupt My Sleep? Tirzepatide for Sleep Apnea? The

May contribute to greater vitality and day-to-day performance

This same principle applies when comparing semaglutide, tirzepatide, and future medications such as retatrutide

Some patients find that taking their injection in the evening rather than morning reduces daytime gastrointestinal symptoms

Users and studies report: Deeper, uninterrupted sleep: DSIP may reduce nighttime awakenings, supporting a more continuous sleep cycle

Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy

[Google Scholar] Therapeutic peptides: Current applications and future directions